{
    "root": "35a568f3-83cc-452e-e063-6394a90a8c1d",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Trazodone Hydrochloride",
    "value": "20250521",
    "ingredients": [
        {
            "name": "CELLULOSE, MICROCRYSTALLINE",
            "code": "OP1R32D61U"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30563"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_16189"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "STARCH, PREGELATINIZED CORN",
            "code": "O8232NY3SJ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "TRAZODONE HYDROCHLORIDE",
            "code": "6E8ZO8LRNM",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_9655"
        }
    ],
    "indications": {
        "text": "trazodone hydrochloride tablets selective serotonin reuptake inhibitor indicated treatment major depressive disorder ( mdd ) ( 1 ) .",
        "doid_entities": [
            {
                "text": "major depressive disorder (DOID:1470)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1470"
            },
            {
                "text": "depressive disorder (DOID:1596)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1596"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "starting dose : 150 mg divided doses daily . may increased 50 mg per day every three four days . maximum dose : 400 mg per day divided doses ( 2 ) . trazodone hydrochloride tablets taken shortly meal light snack ( 2 ) . tablets swallowed whole broken half along score line , chewed crushed ( 2 ) . discontinued , gradual dose reduction recommended ( 2 ) .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "trazodone hydrochloride tablets , usp 150 mg available oral white white , oval , flat faced beveled edge uncoated tablets full bisect two partial trisects . debossed `` 13 `` bisect `` 32 `` one side `` 50 50 50 `` side . 150 mg , entire tablet . ndc : 70518-3479-00 ndc : 70518-3479-01 ndc : 70518-3479-02 packaging : 30 1 bottle plastic packaging : 30 1 blister pack packaging : 90 1 bottle plastic store 20\u00b0 25\u00b0c ( 68\u00b0 77\u00b0f ) . excursions permitted 15\u00b0 30\u00b0c ( 59\u00b0 86\u00b0f ) [ usp controlled room temperature ] . dispense child-resistant closure tight , light-resistant container defined usp . repackaged distributed : remedy repack , inc. 625 kolter dr. suite # 4 indiana , pa 1-724-465-8762",
    "adverseReactions": "concomitant monoamine oxidase inhibitors ( maois ) , within 14 days stopping maois ( 4 ) .",
    "indications_original": "Trazodone hydrochloride tablets are a selective serotonin reuptake inhibitor indicated for the treatment of major depressive disorder (MDD) ( 1 ).",
    "contraindications_original": "Starting dose: 150 mg in divided doses daily. May be increased by 50 mg per day every three to four days. Maximum dose: 400 mg per day in divided doses ( 2 ). Trazodone hydrochloride tablets should be taken shortly after a meal or light snack ( 2 ). Tablets should be swallowed whole or broken in half along the score line, and should not be chewed or crushed ( 2 ). When discontinued, gradual dose reduction is recommended ( 2 ).",
    "warningsAndPrecautions_original": "Trazodone Hydrochloride Tablets, USP 150 mg are available for oral administration as white to off white, oval, flat faced beveled edge uncoated tablets with a full bisect and two partial trisects. Debossed \"13\" bisect \"32\" on one side and \"50 50 50\" on other side.\n                  For 150 mg, use the entire tablet.\n                  \n                  NDC: 70518-3479-00\n                  NDC: 70518-3479-01\n                  NDC: 70518-3479-02\n                  PACKAGING: 30 in 1 BOTTLE PLASTIC\n                  PACKAGING: 30 in 1 BLISTER PACK\n                  PACKAGING: 90 in 1 BOTTLE PLASTIC\n                  \n                  Store at 20\u00b0 to 25\u00b0C (68\u00b0 to 77\u00b0F). Excursions permitted between 15\u00b0 to 30\u00b0C (59\u00b0 to 86\u00b0F)\u00a0[see USP Controlled Room Temperature].\n                  Dispense with a child-resistant closure in a tight, light-resistant container as defined in the USP.\n                  \n                  Repackaged and Distributed By:\n                  Remedy Repack, Inc.\n                  625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762",
    "adverseReactions_original": "Concomitant use of monoamine oxidase inhibitors (MAOIs), or use within 14 days of stopping MAOIs ( 4 ).",
    "drug": [
        {
            "name": "Trazodone Hydrochloride",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_9655"
        }
    ]
}